Takeda offloads $670M of European drugs as consumer health sale rumors resurface

24th April 2020 Uncategorised 0

Inching closer to its selloff target of $10 billion, Takeda has agreed to sell about 110 European drugs and two manufacturing sites to Danish company Orifarm for up to $670 million, just as rumors surfaced that the Japanese pharma was looking to sell its Japanese consumer health unit for about $3.7 billion.

More: Takeda offloads 0M of European drugs as consumer health sale rumors resurface
Source: fierce